Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): An open-label, non-inferiority, randomised controlled trial
- Kathy Pritchard-Jones
- , Christophe Bergeron
- , Beatriz De Camargo
- , Marry M. Van Den Heuvel-Eibrink
- , Tomas Acha
- , Jan Godzinski
- , Foppe Oldenburger
- , Liliane Boccon-Gibod
- , Ivo Leuschner
- , Gordan Vujanic
- , Bengt Sandstedt
- , Jan De Kraker
- , Harm Van Tinteren
- , Norbert Graf
Research output: Contribution to journal › Article › peer-review
182
Citations
(Scopus)